Full-Time

Senior Python Engineer

Updated on 5/8/2026

Inizio

Inizio

5,001-10,000 employees

Guides clinical development and commercialization

No salary listed

Manchester, UK

Remote

Occasional travel within the UK.

Category
Software Engineering (1)
Required Skills
Kubernetes
Microsoft Azure
FastAPI
Python
Git
Infrastructure as Code (IaC)
Docker
CloudFormation
Microservices
AWS
Terraform
REST APIs
Flask
Django
Requirements
  • Strong professional experience as a Python engineer, building and operating production systems (e.g., SaaS platforms, backend services, data-driven applications).
  • Deep knowledge of Python fundamentals, including application architecture, performance considerations, testing, and maintainability.
  • Experience building backend systems using frameworks such as FastAPI, Flask, Django, or similar.
  • Solid understanding of cloud-based architectures (AWS and/or Azure), containers, and microservices.
  • Experience working with CI/CD pipelines, version control, and modern development workflows.
  • Strong debugging and problem-solving skills in distributed or data-heavy systems.
  • Comfortable collaborating in cross-functional, Agile teams and taking ownership of delivered solutions.
  • Curious, pragmatic, and motivated by building reliable systems that deliver real-world impact.
Responsibilities
  • Design, build, deploy, and maintain scalable Python services and APIs using modern backend and cloud-native patterns.
  • Develop clean, testable, and well-structured Python code for data-intensive and workflow-driven applications.
  • Build and integrate backend components that support AI-enabled features (e.g., orchestration layers, inference services, data pipelines).
  • Integrate with third-party APIs and external services, ensuring reliability, performance, and cost efficiency.
  • Own production concerns including logging, monitoring, error handling, and performance optimisation.
  • Contribute to CI/CD pipelines, infrastructure-as-code, and containerised deployments.
  • Collaborate with product, data, and engineering stakeholders to translate requirements into high-quality technical solutions.
  • Write clear technical documentation for engineers and non-technical audiences.
  • Contribute to a collaborative, pragmatic, and high-quality engineering culture.
Desired Qualifications
  • Exposure to data platforms or analytics workflows (e.g., Databricks, Airflow).
  • Familiarity with LLMs, generative AI APIs, or AI-enabled application patterns.
  • Experience with observability and monitoring tools (e.g., Prometheus, Grafana, Sentry).
  • Contributions to open-source projects or shared internal libraries.
  • Experience in regulated or high-compliance domains (e.g., healthcare, life sciences, finance).

Inizio helps health and life sciences companies develop and commercialize products to maximize patient access. It uses a connected suite of capabilities and expert guidance to navigate assets through their entire lifecycle with tailored strategies. Unlike firms that offer single services, Inizio combines multiple capabilities in an end-to-end approach focused on reducing complexity and ensuring lifecycle support. Its goal is to bring therapies to patients faster and more effectively by coordinating development, regulatory, market access, and commercialization activities to maximize value and treatment outcomes.

Company Size

5,001-10,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Colin Stanley's CCO appointment on February 6, 2025, drives commercialization growth with 25 years' experience.
  • Patrick Giordani as SVP AI Solutions Architect bolsters AI innovation in medical affairs communications.
  • Nazaré unites 150 experts to enhance employee performance via immersive learning experiences.

What critics are saying

  • Intelligent Automation Congress on March 3-4, 2026, erodes edge with superior AI event automation.
  • Nazaré launch cannibalizes Intelligent Congress budgets, diverting funds to internal learning.
  • Patrick Giordani's AI fails by end-2026, causing client exodus to IA Congress AI networks.

What makes Inizio unique

  • Intelligent Congress integrates strategy, design, delivery, and measurement across congress lifecycles.
  • Inizio supports 175 congresses yearly for 100% of top 20 pharma companies across 50 countries.
  • Four-step framework captures real-time insights from over 25,500 attendees and 1,000 HCP engagements.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Performance Bonus

Professional Development Budget

Hybrid Work Options

Company News

PR Newswire
Feb 6th, 2025
Inizio Accelerates Growth With A Trio Of Strategic Leadership Appointments

LONDON, Feb. 6, 2025 /PRNewswire/ -- Inizio, a commercialization partner for health and life science companies, has today announced the appointment of Colin Stanley as Chief Commercial Officer (CCO), Remco op den Kelder as President of Inizio Advisory and Jim Sage as President of Inizio Engage.Stepping into the CCO role, Colin brings over 25 years of sector experience and a proven track record in business growth in the industry, from CRO and commercialization

Bio-IT World
Oct 20th, 2024
Inizio Medical Appoints Patrick Giordani as SVP, AI Solutions Architect, Underpinning Commitment to Expanding AI Capabilities and Accelerating Innovation

Inizio Medical, the leading provider of Medical Affairs and communications solutions, today announced the appointment of Patrick Giordani as Senior Vice President, AI Solutions Architect.

Bio-IT World
Oct 14th, 2024
Inizio Medical Appoints Matt Wadyka as President, US Medical Affairs

Bio-IT World Inc is immensely proud that Matt has chosen to join Inizio Medical and contribute to its mission of providing exceptional medical communications and specialized solutions.

PR Newswire
Oct 18th, 2023
Inizio Engage Launches New Global Powerhouse Learning Brand, Nazaré

FORT WASHINGTON, Pa., Oct. 18, 2023 /PRNewswire/ -- Inizio Engage has announced the launch of Nazaré, a new learning and capability brand. Nazaré brings together 150+ experts in learning, life sciences, creativity, technology, and behavioral science. Nazaré is set to transform workplace learning in order to help companies maintain their leadership in evolving competitive landscapes by unlocking the potential of their people.The new global learning and capability brand will be part of the Experience Design (XD) specialist area within Inizio Engage. This means Nazaré will draw on the rest of Inizio Engage XD's in-house creative and executional capabilities in live events, environments, film, digital, and immersive technologies, as well as considering learning experience design more holistically alongside employee engagement.Nazaré brings together Axiom, Cormis, Logicearth Learning Services and Ashfield Excellence Academy under one brand to support global organizations with a range of learning and capability programs, with an unparalleled level of expertise in end-to-end life sciences learning support for pharmaceutical and biotech companies across the product lifecycle. Nazaré will focus on designing and delivering world-class learning experiences that inspire an immediate and lasting change in performance.Nazaré harnesses science, creativity, and technology to challenge how the Learning & Development industry creates impact for businesses

PR Newswire
Sep 14th, 2023
Innovative Collaboration: Buzzreach And Oncoshot Spearhead Clinical Trial Advancements In Japan

SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan. The former specialises in clinical trial site recruitment and retention and project management solutions, while the latter operates a cutting-edge real-time health insights exchange platform.Mr Taketeru Inokawa (left) and Dr Huren Sivaraj (right) during the MOU signing ceremony in Singapore.The collaboration will extend to Oncoshot's strategic contract research organisation and pharmaceutical partners. Together, they will focus on recruiting participants for upcoming studies scheduled to begin in Q1 2024."This collaboration marks a significant step in Oncoshot's vision of creating a cancer cohort discovery platform and upcoming national-level clinical trials ecosystems and hospitals globally," said Oncoshot CEO Dr Huren Sivaraj.Central to this partnership is the cost-free infrastructure designed to facilitate the real-time exchange of aggregated insights. This ground-breaking initiative is set to synergise their complementary strengths to enhance various clinical trial aspects throughout Japan, including feasibility assessments, participant screening, and enrolment. Japan is currently ranked as the third-largest pharmaceutical market worldwide